APA

Pozniak A., Arribas J. R., Gathe J., Gupta S. K., Post F. A., Bloch M., Avihingsanon A., Crofoot G., Benson P., Lichtenstein K., Ramgopal M., Chetchotisakd P., Custodio J. M., Abram M. E., Wei X., Cheng A., McCallister S., SenGupta D. & Fordyce M. W. (20160720). Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Pozniak Anton, Arribas Jose R, Gathe Joseph, Gupta Samir K, Post Frank A, Bloch Mark, Avihingsanon Anchalee, Crofoot Gordon, Benson Paul, Lichtenstein Kenneth, Ramgopal Moti, Chetchotisakd Ploenchan, Custodio Joseph M, Abram Michael E, Wei Xuelian, Cheng Andrew, McCallister Scott, SenGupta Devi and Fordyce Marshall W. 20160720. Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Pozniak A., Arribas J. R., Gathe J., Gupta S. K., Post F. A., Bloch M., Avihingsanon A., Crofoot G., Benson P., Lichtenstein K., Ramgopal M., Chetchotisakd P., Custodio J. M., Abram M. E., Wei X., Cheng A., McCallister S., SenGupta D. and Fordyce M. W. (20160720). Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. : Journal of acquired immune deficiency syndromes (1999).

MLA

Pozniak Anton, Arribas Jose R, Gathe Joseph, Gupta Samir K, Post Frank A, Bloch Mark, Avihingsanon Anchalee, Crofoot Gordon, Benson Paul, Lichtenstein Kenneth, Ramgopal Moti, Chetchotisakd Ploenchan, Custodio Joseph M, Abram Michael E, Wei Xuelian, Cheng Andrew, McCallister Scott, SenGupta Devi and Fordyce Marshall W. Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. : Journal of acquired immune deficiency syndromes (1999). 20160720.